Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer (Q79320537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1

Dawn Hershman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

7

Alfred I Neugut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Michael J Hall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Xiaoyan Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Judith S Jacobson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Russell McBride

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Victor R Grann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2581-2588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Racial disparities in treatment and survival among women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Explaining black-white differences in receipt of recommended colon cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Completion of therapy by Medicare patients with stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Delay in diagnosis and treatment of symptomatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Delay in treatment of colorectal cancer: multifactorial problem

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Development of a comorbidity index using physician claims data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Racial differences in the treatment of early-stage lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Assessing illness severity: does clinical judgment work?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Assessing comorbidity using claims data: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Age and adjuvant chemotherapy use after surgery for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Does Timing of Adjuvant Chemotherapy for Early Breast Cancer Influence Survival?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Measurement and impact of comorbidity in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Comorbidity and functional status are independent in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22316

7 January 2021

Identifiers

DOI

10.1002/CNCR.22316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078055%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference